Andrew Jones

Andrew Jones
I’m a post-doctoral researcher at the University of Liverpool. My main research is in experimental psychology, specifically examining cognitive and behavioural processes in addiction. I hold more broad interests in motivational processes in general and how they are related to different psychopathologies. I have recently started blogging (http://livuniaddictiongroup.blogspot.co.uk/) and tweeting (ajj_1988) as I find it an easy and enjoyable way to share the research that interests me!

Website

Follow me here –

Which personality traits may protect us from alcohol use disorder?

1 Response »
Andrew Jones
Posted by
eeshan-garg-263528

Andrew Jones summarises a recent systematic review and meta-analysis of alcohol treatment outcome, which identifies a range of personality traits that are associated with relapse.

[read the full story...]

Severe mental illness in offspring may not be linked to smoking during pregnancy

No Responses »
Andrew Jones
Posted by
baby-2022446_1280

Andrew Jones considers a recent cohort study that looks into the associations between maternal smoking during pregnancy and severe mental illness in offspring.

[read the full story...]

Substance misuse and addiction in people with intellectual and developmental disabilities

30 Responses »
Andrew Jones
Posted by
drinking-997189_640

Andrew Jones summarises a recent Canadian cohort study, which explores the extent of substance misuse and addictive disorders among adults with intellectual and developmental disabilities.

[read the full story...]

Can pharmacotherapy help smokers with severe mental disorders?

25 Responses »
Andrew Jones
Posted by
25470348902_cd8daa9fed_k

Andrew Jones reports on an ecological pragmatic clinical trial, which suggests that it is feasible to support smoking cessation in people with severe mental disorders such as bipolar disorder and schizophrenia.

[read the full story...]

Pharmacotherapy for smoking cessation in severe mental illness

71 Responses »
Andrew Jones
Posted by
photo-1429035429336-ad854ea8a720

Andrew Jones reports on a recent systematic review and network meta-analysis of the efficacy and tolerability of pharmacotherapy for smoking cessation in severe mental illness, which finds a promising but low quality result for bupropion and varenicline.

[read the full story...]

Should we stigmatise smokers?

57 Responses »
Andrew Jones
Posted by
17174003592_365bef1db6_k

Andrew Jones on a recent systematic review that brings together quantitative and qualitative research about the positive and negative impact of tobacco cessation campaigns and measures. The review concludes that stigmatising of smoking can lead to unintended consequences, such as increased stress, social isolation and smoking relapse.

[read the full story...]

Cigarette smoking may enhance vulnerability for cannabis dependence

49 Responses »
Andrew Jones
Posted by
8096285_a5de9dbac0_b

Andrew Jones considers the findings of a longitudinal study of young cannabis users in the UK, which highlights an association between cigarette smoking and cannabis dependence.

[read the full story...]

Substance use disorders increase mortality following release from prison

59 Responses »
Andrew Jones
Posted by
shutterstock_109899941

Andrew Jones summarises a recent nationwide longitudinal cohort study, which explores the relationship between substance use disorders, psychiatric disorders, and mortality after release from prison.

[read the full story...]

Childhood adversity linked to psychotropic drug use in later life

71 Responses »
Andrew Jones
Posted by
shutterstock_121428757

Andrew Jones summarises a large Finnish population-based cohort study, which finds that childhood adversities strongly predict the use of psychotropic drugs (such as antidepressants and antipsychotics) in adulthood.

[read the full story...]